Verfasser Suchresultate

Normdaten (Quelle GND / Entity Facts )

Dominik Bettinger

geboren 1985 in Rottweil
Arzt

Biografische Angaben
Diss. 2013, Universität Freiburg, Medizinische Fakultät

Wirkungsort
Freiburg im Breisgau

Weiterführende Links

Gemeinsame Normdatei (GND) im Katalog der Deutschen Nationalbibliothek

Open Researcher and Contributor ID (ORCID)

Deutsche Digitale Bibliothek

Virtual International Authority File (VIAF)

Wikidata

International Standard Name Identifier (ISNI)

Albi grade enables risk stratification for bleeding events and refines prognostic prediction in advanced HCC following atezolizumab and bevacizumab

Stefanini, Bernardo (Verfasser)

Freiburg : Universität, 2025

E-Book

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as prognostic biomarkers in unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab

Wu, Yue Linda (Verfasser)

Freiburg : Universität, 2022

E-Book

Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study

Marinelli, Brett (Verfasser)

Freiburg : Universität, 2022

E-Book

Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC

Sharma, Rohini (Verfasser)

Freiburg : Universität, 2022

E-Book

Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study

Fulgenzi, Claudia Angela Maria (Verfasser)

Freiburg : Universität, 2022

E-Book

The systemic inflammatory response identifies patients with adverse clinical outcome from immunotherapy in hepatocellular carcinoma

Muhammed, Ambreen (Verfasser)

Freiburg : Universität, 2022

E-Book

Early antibiotic exposure is not detrimental to therapeutic effect from immunotherapy in hepatocellular carcinoma

Fessas, Petros (Verfasser)

Freiburg : Universität, 2021

E-Book

Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy

Pinato, David James (Verfasser)

Freiburg : Universität, 2020

E-Book

Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study

Fessas, Petros (Verfasser)

Freiburg : Universität, 2020

E-Book

Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib

Labeur, Tim A. (Verfasser)

Freiburg : Universität, 2020

E-Book

Prediction of survival among patients receiving transarterial chemoembolization for hepatocellular carcinoma : : a response‐based approach

Han, Guohong (Verfasser)

Freiburg : Universität, 2020

E-Book

Immunotherapy in hepatocellular cancer patients with mild to severe liver dysfunction: adjunctive role of the ALBI grade

Pinato, David James (Verfasser)

Freiburg : Universität, 2020

E-Book

Deep sequencing of circulating tumour DNA as a biomarker of clinical outcome to transarterial chemoembolisation in hepatocellular carcinoma

Sharma, Rohini (Verfasser)

Freiburg : Universität, 2025

E-Book

A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma

Balcar, Lorenz (Verfasser)

Freiburg : Universität, 2024

E-Book

Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: an international observational study

Xia, Dongdong (Verfasser)

Freiburg : Universität, 2024

E-Book

Progression patterns and therapeutic sequencing following immune checkpoint inhibition for HCC : : an international observational study

Talbot, Thomas (Verfasser)

Freiburg : Universität, 2023

E-Book

Impact of COVID-19 on 1-zear survival outcomes in hepatocellular carcinoma : : a multicenter cohort study

De Souza, Shuell (Verfasser)

Freiburg : Universität, 2023

E-Book

Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma

Dharmapuri, Sirish (Verfasser)

Freiburg : Universität, 2024

E-Book

Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma

Vithayathil, Mathew (Verfasser)

Freiburg : Universität, 2022

E-Book

Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: a real‐world study

D’Alessio, Antonio (Verfasser)

Freiburg : Universität, 2022

E-Book

Treffer 1 - 20 von 83

Dominik Bettinger

Weiterführende Links

Seite in der Trefferliste auswählen

Seite in der Trefferliste auswählen

Suche einschränken